
    
      The objective of this study is to evaluate the dose-response of three different dose levels
      of STA-2 (900 mg daily, 1800 mg daily and 2700 mg daily for 42 days) versus placebo in
      patients with chronic stable angina.

      Treatment Group A:

      150 mg STA-2, 2 capsules t.i.d., after meal (900 mg STA-2 total dose per day)

      Treatment Group B:

      300 mg STA-2, 2 capsules t.i.d., after meal (1800 mg STA-2 total dose per day)

      Treatment Group C:

      450 mg STA-2, 2 capsules t.i.d., after meal (2700 mg STA-2 total dose per day)

      Placebo Group:

      Placebo capsule, 2 capsules t.i.d., after meal
    
  